Landscape of GLP-1R-Targeted Drug Development Mainstream: Peptide-Based GLP-1R Drugs Due to GLP-1R's dual role in regulating blood glucose and promoting weight loss, it has become a key target in diabetes treatments and aesthetic medicine
This post explores the safety, research, and practical considerations of using glutathione for liver support
With love and gratitude
Common reasons for getting off a GLP-1 include: Persistent nausea, vomiting, diarrhea, constipation, or fatigue Medication costs or changes in insurance coverage Difficulty obtaining the prescribed medication Pregnancy or plans to become pregnant Reaching a personal weight goal Limited treatment response A change in health status A provider-recommended medication change A preference to manage weight without medication Why Stopping GLP-1s Causes Noticeable Changes Before discussing outcomes, it helps to understand how GLP-1 medications work and why their effects do not persist once dosing stops
Interactions between gut microbiota and acute restraint stress in peripheral structures of the hypothalamicpituitaryadrenal axis and the intestine of male mice
In the context of peptides like CJC-1295, DAC refers to a molecular modification that extends the half-life of the peptide in the body